THERAPEUTIC STRATEGY COMBINING INTRAVENOUS CYCLOPHOSPHAMIDE FOLLOWED BY ORAL MYCOPHENOLATE MOFETIL TO TREAT SEVERE OR WORSENING INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS

被引：0
|
作者：
Duchange, Al [1 ]
Mouthon, L. [2 ]
Berezne, A. [2 ]
Morell-Dubois, S. [1 ]
Hatron, P. Y. [1 ]
Guillevin, L. [2 ]
Hachulla, E. [1 ]
Launay, D. [1 ]
机构：
[1] Hop Claude Huriez, Ctr Reference Sclerodermie, CHRU, Serv Med Interne, Lille, France
[2] Hop Cochin, Ctr Reference Vasc & Sclerodermie, Serv Med Interne, F-75674 Paris, France
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2010年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [41] THE EFFECT OF CYCLOPHOSPHAMIDE ON LUNG FUNCTION IN DIFFERENT STAGES OF INTERSTITIAL LUNG DISEASE ASSOCIATED TO SYSTEMIC SCLEROSIS
    Van Den Hombergh, W. M. T.
    Teesselink, E.
    Knaapen-Hans, H. K. A.
    Simons, S. O.
    van den Hoogen, F. H. J.
    Fransen, J.
    Vonk, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 526 - 526
  • [42] Scleroderma Lung Study Ii: Comparison Of Therapy With Mycophenolate Mofetil Versus Oral Cyclophosphamide In Patients With Symptomatic Scleroderma Interstitial Lung Disease
    Tashkin, D. P.
    Roth, M. D.
    Furst, D. E.
    Clements, P.
    Khanna, D.
    Volkmann, E.
    Kalafa, S.
    Goldin, J.
    Kim, G. H. J.
    Arriola, E.
    Tseng, C. -H.
    Elashoff, R. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [43] Efficacy of Mycophenolate Associated with Methotrexate as a Maintenance Treatment for Systemic Sclerosis-Associated Interstitial Lung Disease
    Antonio Gonzalez-Nieto, Jose
    Javier Martin-Suarez, Ignacio
    Luis Gil-Munoz, Francisco
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (11): : 575 - 575
  • [44] Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease
    Kim, Grace Hyun J.
    Tashkin, Donald P.
    Lo, Pechin
    Brown, Matthew S.
    Volkmann, Elizabeth R.
    Gjertson, David W.
    Khanna, Dinesh
    Elashoff, Robert M.
    Tseng, Chi-Hong
    Roth, Michael D.
    Goldin, Jonathan G.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (02) : 316 - 325
  • [45] A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease
    Várai, G
    Earle, L
    Jimenez, SA
    Steiner, RM
    Varga, J
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (07) : 1325 - 1329
  • [46] Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression
    Narvaez, Javier
    LLuch, Judit
    Molina-Molina, Maria
    Vicens-Zygmunt, Vanesa
    Luburich, Patricio
    Anibal Yanez, Marcos
    Nolla, Joan M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 977 - 987
  • [47] Successful use of intravenous cyclophosphamide pulse therapy for interstitial lung disease in a patient with systemic sclerosis on hemodialysis
    Takahashi, Takehiro
    Asano, Yoshihide
    Sunaga, Ryo
    Ichimura, Yohei
    Taniguchi, Takashi
    Yamamoto, Mizuho
    Tamaki, Zenshiro
    Takekoshi, Tomonori
    Mitsui, Hiroshi
    Sugaya, Makoto
    Ohse, Takamoto
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2014, 41 (06): : 533 - 535
  • [48] Pulse intravenous methylprednisolone and cyclophosphamide is effective in treating interstitial lung disease in patients with systemic sclerosis.
    Griffiths, B
    Miles, S
    Morgan, A
    Lian, T
    Bingham, S
    Veale, D
    Emery, P
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S190 - S190
  • [49] Effectiveness and Safety of Tacrolimus Following Intravenous Cyclophosphamide Pulse Therapy As the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease
    Ichimura, Yuki
    Kawaguchi, Yasushi
    Takagi, Kae
    Tochimoto, Akiko
    Higuchi, Tomoaki
    Katsumata, Yasuhiro
    Yamanaka, Hisashi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [50] Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease An Analysis of Scleroderma Lung Studies I and II
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Li, Ning
    Roth, Michael D.
    Khanna, Dinesh
    Hoffmann-Vold, Anna-Maria
    Kim, Grace
    Goldin, Jonathan
    Clements, Philip J.
    Furst, Daniel E.
    Elashoff, Robert M.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (07) : 1451 - 1460
12345